The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature

• Publication date

  2017-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature22353PMID 28562582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

  2017cited by this paper
• Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival

  2016cited by this paper
• Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function

  2016cited by this paper
• Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

  2016cited by this paper
• Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

  2015cited by this paper
• B-cell receptor signaling in diffuse large B-cell lymphoma.

  2015cited by this paper
• The B-cell antigen receptor integrates adaptive and innate immune signals

  2015cited by this paper
• Maui-VIA: A User-Friendly Software for Visual Identification, Alignment, Correction, and Quantification of Gas Chromatography–Mass Spectrometry Data

  2015cited by this paper
• Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis

  2014cited by this paper
• Oncogenic mechanisms in Burkitt lymphoma.

  2014cited by this paper
• Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies

  2014cited by this paper
• Pulsed stable isotope-resolved metabolomic studies of cancer cells.

  2014cited by this paper
• Decoding the dynamics of cellular metabolism and the action of 3-bromopyruvate and 2-deoxyglucose using pulsed stable isotope-resolved metabolomics

  2014cited by this paper
• Targeting pathological B cell receptor signalling in lymphoid malignancies

  2013cited by this paper
• Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.

  2013cited by this paper
• SAVI: a statistical algorithm for variant frequency identification

  2013cited by this paper
• Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

  2013cited by this paper
• Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

  2012cited by this paper
• Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

  2012cited by this paper
• Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

  2012cited by this paper
• Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

  2012cited by this paper
• Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

  2010cited by this paper
• Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine

  2010cited by this paper
• Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation

  2010cited by this paper
• PI3 kinase signals BCR-dependent mature B cell survival.

  2009cited by this paper
• An automated GCxGC‐TOF‐MS protocol for batch‐wise extraction and alignment of mass isotopomer matrixes from differential 13C‐labelling experiments: a case study for photoautotrophic‐mixotrophic grown Chlamydomonas reinhardtii cells

  2009cited by this paper
• Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage.

  2009cited by this paper
• DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization

  2008cited by this paper
• The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas

  2008cited by this paper
• Vagaries of conditional gene targeting

  2007cited by this paper
• GMD@CSB.DB: the Golm Metabolome Database

  2005cited by this paper
• Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer

  2004cited by this paper
• Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer.

  2004cited by this paper
• B cell receptor signal strength determines B cell fate

  2004cited by this paper
• Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

  2004cited by this paper
• Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

  2003cited by this paper
• Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

  2003cited by this paper
• Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes

  2002cited by this paper
• The renaissance of GSK3

  2001cited by this paper
• Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development

  2000cited by this paper
• Burkitt Lymphoma in the Mouse

  2000cited by this paper
• The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.

  1999cited by this paper
• In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

  1997cited by this paper

• Targetable Vulnerabilities in MYC‐Driven B Cell Lymphomas Resistant to BCR Extinction

  2026cites this paper
• Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

  2026cites this paper
• CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

  2025cites this paper
• B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements

  2025cites this paper
• The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma

  2025cites this paper
• IgAim: cell surface Ig-aimed immune memory erasers for the therapy of autoimmune diseases and B leukemia

  2025cites this paper
• The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

  2025cites this paper
• A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies

  2024cites this paper
• How I diagnose high-grade B-cell lymphoma.

  2024cites this paper
• Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance

  2024cites this paper
• Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen

  2024cites this paper
• Mutations in the IgG B cell receptor associated with class-switched B cell lymphomas

  2024influential citation
• Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment.

  2024cites this paper
• Antigen receptor structure and signaling.

  2023cites this paper
• Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma

  2023cites this paper
• Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation

  2023cites this paper
• A Germline Point Mutation in the MYC-FBW7 Phosphodegron Initiates Hematopoietic Malignancies

  2023cites this paper
• From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia.

  2023cites this paper
• Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop

  2023cites this paper
• Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.

  2023cites this paper
• Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas

  2022cites this paper
• Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling

  2022cites this paper
• Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies

  2022cites this paper
• Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression

  2022cites this paper
• The metabolic plasticity of B cells

  2022influential citation
• Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

  2022cites this paper
• Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  2022cites this paper
• l‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma

  2022cites this paper
• Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies

  2022cites this paper
• “Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes

  2022cites this paper
• Mouse Models of Germinal Center Derived B-Cell Lymphomas

  2021cites this paper
• In situ transcriptional profile of a germinal center plasmablastic burst hints at an unfavorable Diffuse Large B-cell Lymphoma subset.

  2021cites this paper
• Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.

  2021cites this paper
• Tilting MYC toward cancer cell death.

  2021cites this paper
• Accumulation of the GSK3 target protein β-catenin is lethal for B cell precursors and malignant B cells

  2021influential citation
• Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.

  2021cites this paper
• Glutamine promotes the generation of B10+ cells via the mTOR/GSK3 pathway

  2021cites this paper
• Histone Modifications and Their Targeting in Lymphoid Malignancies

  2021cites this paper
• Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

  2020cites this paper
• Mouse Models in the Study of Mature B-Cell Malignancies.

  2020cites this paper
• Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies

  2020cites this paper
• Immunoglobulin expression in the endoplasmic reticulum shapes the metabolic fitness of B lymphocytes

  2020cites this paper
• The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies

  2020cites this paper
• Intra-tumor heterogeneity of Diffuse Large B-cell Lymphoma involves the induction of diversified stroma-tumor interfaces

  2020cites this paper
• The role of metabolic checkpoint regulators in B cell survival and transformation

  2020cites this paper
• JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells

  2020cites this paper
• Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces

  2020cites this paper
• Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview

  2020cites this paper
• MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities

  2019cites this paper
• Germinal center‐derived lymphomas: The darkest side of humoral immunity

  2019cites this paper
• The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance

  2019cites this paper
• Non‐leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma

  2019cites this paper
• The potential role of glycogen metabolism in diffuse large B-cell lymphoma

  2019cites this paper
• New responsibilities for aged kinases in B‐lymphomas

  2019cites this paper
• Bruton Tyrosine Kinase Inhibitors

  2019cites this paper
• GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways

  2019cites this paper
• Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence

  2019cites this paper
• Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment

  2019cites this paper
• PD-L1 over-expression is driven by B-cell receptor signaling in diffuse large B-cell lymphoma

  2019cites this paper
• Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma

  2018cites this paper
• Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells

  2018cites this paper
• Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.

  2018cites this paper
• B-Cell Metabolic Remodeling and Cancer.

  2018cites this paper
• IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.

  2018cites this paper
• Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines

  2018cites this paper
• B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

  2018cites this paper
• BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.

  2018cites this paper
• UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma

  2018cites this paper
• Targeting B cell receptor signalling in cancer: preclinical and clinical advances

  2018cites this paper
• Papers of note in Nature 546 (7657)

  2017cites this paper
• A Brake for B Cell Proliferation

  2017cites this paper
• Les lymphomes B diffus à grandes cellules de type activé : rôle de NF-κB et c-Myc.

  2017cites this paper
• EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.

  2017cites this paper